need for agents with an enlarged spectrum of activity. The discovery of carbenicillin added Pseudomonas aeruginosa, Enterobacter cloacae, and less commonly encountered species such as Acinetobacter calcoaceticus and the indole-positive Proteus to the spectrum of organisms inhibited by penicillins. Ticarcillin has a two-to fourfold greater activity than carbenicillin against Pseudomonas, but it is no more active than carbenicillin against members of the Enterobacteriaceae (7) . Neither carbenicillin nor ticarcillin is active against Klebsiella, and their activity against Serratia is extremely variable. Strains of Escherichia coli possessing TEM-type /8-lactamases are resistant to all of the commercially available penicillins. Furthermore, the serum and tissue levels of carbenicillin and ticarcillin needed to inhibit many hospitalacquired strains of Pseudomonas are high, and hence the doses of the agents used are also high, resulting in a greater incidence of side effects (1, 5, 6) . We therefore were interested in evaluating the activities of azlocillin and mezlocillin, new broad-spectrum penicillins, and comparing their activity with that of other 83-lactam antibiotics.
(These findings were presented at the 16th Interscience Conference on Antimicrobial Agents and Chemotherapy, 27-29 October 1976, Chicago, Ill.) MATERIALS AND METHODS Azlocillin and mezlocillin were obtained from Delbay Pharmaceuticals. Other antibiotics were gifts from their respective manufacturers. Bacterial strains were those isolated from patients hospitalized at the Columbia-Presbyterian Medical Center. The isolates came from blood, sputum, and urine specimens and did not represent the same strains insofar as could be determined by epidemiological means, general antibiograms, and bacteriocin typing.
Susceptibility tests. The antimicrobial activity was measured by agar dilution or broth dilution methods as previously described in more detail (3) . The minimum inhibitory concentration (MIC) in agar was determined with a replicating device by using a final inoculum on the plate of 105 colony-forming units (CFU). Standard medium used was Mueller-Hinton (BBL). Broth dilution was performed with MuellerHinton broth, with a final inoculum in the assay of 105 CFU. The MIC was the concentration at which there was no visible growth, and the minimum bactericidal concentration (MBC) was the concentration which on subculture yielded fewer than five colonies after 24 h of incubation. 25 ,ug/ml, and 90% were inhibited by 100 iLg/ml. Serratia, on the other hand, was extremely resistant, with only 18% of strains inhibited by 25 jig/ml. Azlocillin inhibited 75% of indole-positive Proteus strains, mainly P. morganii and P. vulgaris, at 25 jig/ ml, but Proteus rettgeri and Providencia stuartii were much more resistant; for these the MICs were greater than 200 jig/ml. Eighty-two percent of Bacteroides fragilis strains were inhibited by 25,ug/ml. However, the most impressive activity was seen with strains of Pseudomonas aeruginosa: 91% of isolates were inhibited by 25 ,ug/ml, and 78% were inhibited by 12.5 jig/ml.
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The in vitro activity of mezlocillin against gram-positive cocci and gram-negative bacilli is shown in Table 2 . The majority of fB-hemolytic streptococci (groups A and B) as well as Streptococcus pneumoniae were inhibited by less than 0.5 jg/ml. Staphylococcus aureus and S. epidermidis that do not produce fi-lactamase were inhibited by less than 0.5 jig/ml, whereas the MICs for fl-lactamase-producing staphylococci were up to 50 jug/ml. (Table 3 ). However, the MIC for a number of Pseudomonas strains was at least eightfold greater than the MIC of both azlocillin and mezlocillin. 89  100  100  100  100  100  100  80  85  100   26  42 55  77  100  82  84  100  16  23 51  81  100  33 53  100  62  92  100  100  57  100  55  61 83 100  100  68  76 88 100  38  59 67  78  100  40  51 73  83  100  53  60 86  89  100  94 100  50  63  62  77  36 55  45  55  9  40  47  26   86  92 95  87  97  87  99 100  68  78 86  88  94 100  94 100  78  83 89  83 100  33  72 100  94 100   82  100  85  100  64  100  63  100  64  100  50  100  54  100  34  100  26  100  9  100  100  99 Table 8 . Azlocillin and mezlocillin were more active than ampicillin and carbenicillin against 8-lactamase-producing Shigella, Klebsiella, Enterobacter, Serratia, and Acinetobacter. However, cefoxitin and cefazolin were the most active against the /i-lactamase-producing strains of E. coli, Shigella, and Providencia tested.
Twelve Pseudomonas aeruginosa isolates resistant to carbenicillin were tested for their susceptibility to azlocillin, mezlocillin, and ticarcillin (Table 9 ). Azlocilhin was more active than ticarcillin against all but one of the carbenicillinresistant Pseudomonas isolates tested, whereas mezlocillin was more active than ticarcillin against some strains.
Hydrolysis of azlocillin and mezlocillin by ,B-lactamases. Partially purified ,B-lactamases of E. coli, Citrobacter, Acinetobacter, Providencia, and Pseudomonas were examined for ability to hydrolyze azlocillin and mezlocillin, and the rates of hydrolysis were compared with 
